» Authors » Dirk Lunz

Dirk Lunz

Explore the profile of Dirk Lunz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 78
Citations 837
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lubnow M, Koch C, Malfertheiner M, Foltan M, Philipp A, Lunz D, et al.
J Clin Med . 2025 Feb; 14(3). PMID: 39941529
Critically ill patients requiring extracorporeal membrane oxygenation (ECMO) have several risk factors to suffer from abdominal compartment syndrome (ACS). Little is known about this subgroup. The aim of this study...
2.
Hofstetter P, Zuber-Jerger I, Mehrl A, Graf B, Lunz D, Lubnow M, et al.
J Gastrointestin Liver Dis . 2024 Jun; 33(2):218-225. PMID: 38944874
Background And Aims: During the coronavirus disease 2019 (COVID-19) pandemic a significant proportion of patients with severe acute respiratory distress syndrome (ARDS) due to COVID-19 infection developed secondary sclerosing cholangitis...
3.
Wiest C, Philipp A, Foltan M, Geismann F, Schneckenpointer R, Baumgartner S, et al.
PLoS One . 2024 Apr; 19(4):e0298342. PMID: 38557873
Objective: In this retrospective case series, survival rates in different indications for veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and differential diagnoses of COVID-19 associated refractory circulatory failure are investigated. Methods: Retrospective...
4.
Trummer G, Benk C, Pooth J, Wengenmayer T, Supady A, Staudacher D, et al.
J Clin Med . 2024 Jan; 13(1). PMID: 38202063
Survival following cardiac arrest (CA) remains poor after conventional cardiopulmonary resuscitation (CCPR) (6-26%), and the outcomes after extracorporeal cardiopulmonary resuscitation (ECPR) are often inconsistent. Poor survival is a consequence of...
5.
Rimboeck J, Gruber M, Weigl M, Huber P, Lunz D, Petermichl W
Biomedicines . 2023 Oct; 11(10). PMID: 37893224
HELLP syndrome is characterized by hemolysis, elevated liver enzymes, and a low platelet count and poses an increased risk to the pregnant woman and the unborn child. Individual risk factors...
6.
Gerhardinger F, Fisser C, Malfertheiner M, Philipp A, Foltan M, Zeman F, et al.
Crit Care Med . 2023 Sep; 52(1):54-67. PMID: 37665263
Objective: Analysis of the prevalence and risk factors for weaning failure from venovenous extracorporeal membrane oxygenation (VV-ECMO) in patients with severe acute respiratory insufficiency. Design: Single-center retrospective observational study. Setting:...
7.
Wiest C, Philipp A, Lunz D, Steinmann J, Eissnert C, Kees M, et al.
Dtsch Arztebl Int . 2023 Mar; 120(4):56-57. PMID: 36949640
No abstract available.
8.
Dropco I, Philipp A, Foltan M, Lunz D, Lubnow M, Lehle K
ASAIO J . 2023 Feb; 69(4):e134-e141. PMID: 36780695
Antithrombogenic coatings of artificial surfaces within extracorporeal membrane oxygenation (ECMO) circuits improved its bio- and hemocompatibility. However, there is still a risk of thrombus formation in particular within the membrane...
9.
Kieninger B, Kilger M, Foltan M, Gruber M, Lunz D, Dienemann T, et al.
PLoS One . 2023 Jan; 18(1):e0280502. PMID: 36662898
Background: Patients with COVID-19 and severe acute respiratory failure may require veno-venous extracorporeal membrane oxygenation (VV ECMO). Yet, this procedure is resource-intensive and high mortality rates have been reported. Thus,...
10.
Baumgartner S, Lubnow M, Malfertheiner M, Philipp A, Foltan M, Lunz D, et al.
ASAIO J . 2022 Dec; 68(12):1529-1535. PMID: 36469449
Bleeding and thromboembolic events are common during veno-venous extracorporeal membrane oxygenation (vvECMO). It is unknown whether these complications are driven by the ECMO system itself, multiorgan-failure, or both. The aim...